| Grene Vision Group Llc | |
|
15 N Highland, Chanite, KS 66720 | |
| (620) 431-3250 | |
| (620) 431-3272 |
| Full Name | Grene Vision Group Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 15 N Highland, Chanite, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922210566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Grene Vision Group Llc 1851 N Webb Rd, Attn Flr2, Wichita, KS 67206-3413 Ph: (316) 636-2010 | Grene Vision Group Llc 15 N Highland, Chanite, KS 66720 Ph: (620) 431-3250 |
News Archive
Microbes present in the gut can affect the severity of kidney disease brought on by melamine poisoning, according to an international study led by Professor Wei Jia at the University of North Carolina in collaboration with the research group of Professor Jeremy Nicholson at Imperial College London.
Two University of Iowa biologists have published a paper on how cells make specific interactions during development - in the hope of one day learning more about human developmental disorders - in the Aug. 2 issue of the journal Proceedings of the National Academy of Sciences.
Roofers and road construction workers who use hot asphalt are exposed to high levels of polycyclic aromatic hydrocarbons (PAHs). A University of Colorado Cancer Center study published this week in the British Medical Journal Open shows that roofers have higher PAH blood-levels after a shift than before and that these high levels of PAHs are linked with increased rates of DNA damage, and potentially with higher cancer risk.
As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers from the Comprehensive Cancer Center at the MedUni Vienna and Vienna General Hospital has now developed a programme that compensates the shortfalls of PSA screening with methods from personalised medicine. As a result, prostate cancer screening is able to reach a new level of quality.
› Verified 9 days ago